IBM (US), Logility (US), CausaLens (UK), Aitia (US), Causely (US), Geminos (US), Data Poem (US), CausaAI (Netherlands), Causa (UK), Lifesight (US), Actable AI (UK). Causal AI Market by Offering (Causal
Naonworks (South Korea), Waterfall Security Solutions (Israel), Infodas (Germany), Siemens (Germany), OPSWAT (US), Advenica (Sweden), Everfox (US), Garland Technology (US), Arbit Cyber Defence Systems (Denmark), Fibersystem (Sweden), VADO Security Technologies
MarketsandMarkets™ Poultry Processing Equipment Market by Equipment Type (Live Bird Handling, Slaughtering & Defeathering, Evisceration, Cut-up & Portioning, Deboning & Filleting, Others), Product Type, Automation Level, Plant Capacity, and Region
MarketsandMarkets™ Europe Biostimulants Market by Active Ingredient (Humic Substances, Seaweed Extracts, Amino Acids, Minerals & Vitamins), Crop Type, Mode Of Application (Foliar Treatment, Soil Treatment), and Form – Forecast To
IGC Pharma, Inc. (NYSE: IGC), a clinical-stage AI biotechnology company focused on Alzheimer’s disease, is gaining investor attention after CEO Ram Mukunda appeared on Bloomberg TV discussing the company’s lead
Sphere 3D Corp. (NASDAQ: ANY) surged more than 100% in early trading, with over $100 million in shares traded, after announcing the completion of its merger with Cathedra Bitcoin, creating
The Key Cancer Anorexia Companies in the market include – Helsinn Healthcare, Artelo Biosciences, NGM Biopharmaceuticals, and others. DelveInsight’s “Cancer Anorexia Market Insights, Epidemiology, and Market Forecast-2036″ report offers
The Key Food Allergy Companies in the market include – Novartis, Roche, ARS Pharmaceuticals, ALK Abelló, Alfresa Pharma, Stallergenes Greer, DBV Technologies, Aravax, Aimmune Therapeutics, Inc., Novartis Pharmaceuticals, DBV Technologies,
The Key Epilepsy Companies in the market include – Aquestive Therapeutics, Atnahs Pharma (Pharmanovia), Jazz Pharmaceuticals, SK Biopharmaceutical, Angelini Pharma/Ono Pharmaceutical, Novartis, Xenon Pharmaceuticals, Takeda, Ovid Therapeutics, Biohaven Pharmaceuticals/Knopp Biosciences,
The Key Alport Syndrome Companies in the market include – Eloxx Pharmaceuticals, Inc., Biogen, River 3 Renal Corp., Travere Therapeutics, Inc. , Chinook Therapeutics U.S., Inc., Bayer, and others.
